Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma

被引：22

作者：

Ciappuccini, Renaud ^{[1
,2
,3
]}

Edet-Sanson, Agathe ^{[4
]}

Saguet-Rysanek, Virginie ^{[5
]}

Gauthe, Mathieu ^{[6
]}

Bardet, Stephane ^{[1
,2
]}

机构：

[1] Francois Baclesse Canc Ctr, Dept Nucl Med, 3 Ave Gen Harris, F-14000 Caen, France

[2] Francois Baclesse Canc Ctr, Thyroid Unit, 3 Ave Gen Harris, F-14000 Caen, France

[3] Normandie Univ, ANTICIPE, INSERM, U1086, Caen, France

[4] Henri Becquerel Canc Ctr, Dept Nucl Med, Rouen, France

[5] Francois Baclesse Canc Ctr, Dept Pathol, Caen, France

[6] Tenon Hosp, AP HP, Dept Nucl Med, Paris, France

来源：

CLINICAL NUCLEAR MEDICINE | 2019年 / 44卷 / 08期

关键词：

thyroid incidentaloma; medullary thyroid cancer; F-18-fluorocholine PET/CT; F-18-choline PET/CT; Ga-68-PSMA PET/CT; prostate cancer; ADENOMA;

D O I：

10.1097/RLU.0000000000002559

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A 66-year-old man with prostate cancer underwent F-18-fluorocholine PET/CT and thereafter Ga-68-labeled prostate-specific membrane antigen PET/CT to explore a rising prostate-specific antigen level. Both PET/CT studies showed a thyroid incidentaloma of the right lobe. Neck ultrasound confirmed the presence of a 16-mm right thyroid nodule. The serum calcitonin level was moderately increased at 25 ng/mL (<10). Cytology was non-diagnostic (Bethesda I). A right lobectomy was performed and pathology revealed a 15-mm medullary thyroid cancer. Two months after surgery, the calcitonin level returned to normal at 3.3 ng/mL.

引用

页码：663 / 665

页数：3

共 50 条

[21] Thyroid metastasis of prostate cancer as a rare entity detected by 68Ga-PSMA PET/CT
Sahin, R.
Guzelbey, B.
Arslan, E.
Ergul, N.
Cermik, T. F.
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2022, 46 (5-6): : 227 - 229
[22] 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma
Sasikumar, Arun
Joy, Ajith
Nanabala, Raviteja
Pillai, M. R. A.
Thomas, Boben
Vikraman, K. R.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (04) : 795 - 796
[23] 68Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma
Arun Sasikumar
Ajith Joy
Raviteja Nanabala
M. R. A. Pillai
Boben Thomas
K. R. Vikraman
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 795 - 796
[24] 68Ga-PSMA PET/CT Detecting Metastatic Lesion of RCC Missed on 18F-FDG PET/CT
Jha, Saurav
Hemrom, Angel
Shamim, Shamim Ahmed
Barwad, Adarsh
Batra, Atul
CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : E294 - E296
[25] Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Wenxiao Yu
Ming Zhao
Yingjun Deng
Shengjing Liu
Guanchao Du
Bin Yan
Ziwei Zhao
Ning Sun
Jun Guo
Cancer Imaging, 23
[26] Medullary Thyroid Carcinoma presenting as an Incidentaloma on Gallium-68-PSMA-PET/CT - Systematic Literature Review and Case Report
Eilsberger, Friederike
Luster, Markus
Librizzi, Damiano
Rodepeter, Fiona
Holzer, Katharina
Pfestroff, Andreas
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (06): : 458 - 461
[27] Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
Yu, Wenxiao
Zhao, Ming
Deng, Yingjun
Liu, Shengjing
Du, Guanchao
Yan, Bin
Zhao, Ziwei
Sun, Ning
Guo, Jun
CANCER IMAGING, 2023, 23 (01)
[28] Incidentalomas on PET-CT with 68Ga-PSMA
Varela Pinto, C.
Martins, B.
Sousa, V.
Loewenthal, C.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S534 - S535
[29] 68Ga-PSMA PET/CT in PCa Staging
不详
JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (11) : 16N - 16N
[30] 68Ga-PSMA PET/CT in prostate cancer
Garcia Garzon, J. R.
de Arcocha Torres, M.
Delgado-Bolton, R.
Ceci, F.
Alvarez Ruiz, S.
Orcajo Rincon, J.
Caresia Aroztegui, A. P.
Garcia Velloso, M. J.
Garcia Vicente, A. M.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138

← 1 2 3 4 5 →